Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

Share Price is delayed by 15 minutes
Get Live Data
26.80    -0.05 (-0.19%)
Bid:
26.25
Ask:
27.00
Spread: 0.75 (2.857%)
Market Cap: £79.14m
SFR Live PriceLast checked at - London Stock Exchange

Intraday Severfield Share Chart

Director/PDMR Shareholding

29 Jul 2025 11:30

RNS Number : 0145T
Severfield PLC
29 July 2025
 

29th July 2025

 

Severfield plc

Notification of Transactions of Directors, Persons Discharging Managerial Responsibilities ("PDMRs") and persons closely associated with them

The following notification relates to the vesting and exercise of nil cost share options granted under the Severfield Deferred Share Bonus Plan ("the Plan") on 28th June 2022 representing part of bonus earned in 2021/22. These options vested on 28th July 2025 and were exercised and settled as set out below.

In accordance with the rules of the Plan and the Company's Directors' Remuneration Policy, where directors chose to exercise and sell the shares they would have acquired, they received a cash payment. This only applied to directors who already satisfy the Company's shareholding requirement. In accordance with the rules of the Plan, where directors chose to exercise and keep their shares, they were awarded shares out of the Severfield EBT to the value of the after tax benefit, with the tax being settled in cash.

 

Name

Number of shares awarded on 28th June 2022

Number of shares vested and exercised on 28th July 2025 after dividend equivalent adjustment

Cash paid to settle tax calculated at a share price of £0.32

Cash to be paid to participant after tax

Shares retained by individual

Adam Semple

34,254

42,943

£6,458

n/a

22,759

 

 

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Adam Semple

2

Reason for the notification

a)

Position/status

CFO

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Severfield plc

b)

LEI

21380025AWPR781CY104

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 2.5p

 

GB00B27YGJ97

 

b)

Nature of the transaction

Exercise of DSBP award made in 2022 representing bonus earned in 2021/22 and settlement of that exercise by cash settling the tax liability and share transfer to the value of the after tax benefit.

c)

Price(s) and volume(s)

 

Price

Volume

Total

Share settlement

£0.32

22,759

£7,282

d)

Aggregated information

-

Aggregated volume

-

Price

 

Not applicable

e)

Date of the transaction

28 July 2025

 

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHRLMMTMTTTBRA
Date   Source Headline
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change
22nd Sep 20224:41 pmRNSSecond Price Monitoring Extn
22nd Sep 20224:36 pmRNSPrice Monitoring Extension
21st Sep 20224:35 pmRNSPrice Monitoring Extension
8th Sep 202211:44 amRNSResult of AGM
8th Sep 20227:31 amRNSProgressive publishes new research
8th Sep 20227:00 amRNSTrading Statement
8th Aug 202212:00 pmRNSNotice of Annual General Meeting and Annual Report
27th Jul 20222:31 pmRNSHolding(s) in Company
25th Jul 20229:40 amRNSDirector/PDMR Shareholding
13th Jul 202211:26 amRNSDirector/PDMR Shareholding
29th Jun 202212:01 pmRNSDirector/PDMR Shareholding
29th Jun 202212:00 pmRNSDirector/PDMR Shareholding
17th Jun 202210:36 amRNSDirector/PDMR Shareholding
15th Jun 20227:29 amRNSProgressive publishes new research
15th Jun 20227:00 amRNSResults for the year ended 26 March 2022
1st Jun 20229:47 amRNSTotal Voting Rights and Share Capital Update
3rd May 20221:12 pmRNSVoting Rights and Share Capital Update
25th Apr 20225:24 pmRNSHolding(s) in Company
20th Apr 20229:38 amRNSProgressive publishes new research
20th Apr 20227:00 amRNSPre-close Trading Update
5th Apr 20224:22 pmRNSHolding(s) in Company
1st Apr 20222:23 pmRNSVoting Rights and Share Capital Update
18th Mar 20224:35 pmRNSPrice Monitoring Extension
17th Mar 20227:00 amRNSAppointment of Joint Broker
10th Mar 20221:59 pmRNSReplacement - Holding(s) in Company
10th Mar 20227:35 amRNSNotice of Change to Director Details
7th Mar 20226:12 pmRNSHolding(s) in Company
2nd Mar 20224:43 pmRNSVoting Rights and Share Capital Update
2nd Mar 20224:40 pmRNSDirector/PDMR Shareholding
2nd Feb 20229:16 amRNSVoting Rights and Share Capital Update
5th Jan 202211:31 amRNSVoting Rights and Share Capital Update
20th Dec 20214:31 pmRNSCompletion of successful refinancing
9th Dec 20217:59 amRNSNotice of Change to Director Details
7th Dec 20213:31 pmRNSDirector/PDMR Shareholding
23rd Nov 20212:17 pmRNSIssue of Ordinary Shares
23rd Nov 20217:57 amRNSProgressive publishes new research
23rd Nov 20217:01 amRNSInterim Dividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.